High-Risk Acute Lymphoblastic Leukemia Cells with bcr-abl and Ink4a/Arf Mutations Retain Susceptibility to Alloreactive T Cells
Open Access
- 1 June 2008
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 14 (6) , 622-630
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Leukemia stem cells in a genetically defined murine model of blast-crisis CMLBlood, 2007
- Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemiaProceedings of the National Academy of Sciences, 2006
- The tumor suppressor p16Ink4a regulates T lymphocyte survivalOncogene, 2006
- p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in miceOncogene, 2006
- Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristicsLeukemia, 2005
- The biology of CML blast crisisBlood, 2004
- Graft-versus-leukemia reactions in allogeneic chimerasBlood, 2004
- Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Unique molecular and cellular features of acute myelogenous leukemia stem cellsLeukemia, 2002
- Characterization of a Murine NKT Cell Tumor Previously Described as an Acute Myelogenous LeukemiaLeukemia & Lymphoma, 2002